News Coverage 07.23.19 By: Amber Tong Share on Twitter Share on Facebook Share on LinkedIn PACT Pharma says it’s perfected the tech to select neoantigens for personalized therapy — now onto the clinic Related Announcement, Our Impact PICI at AACR 2025: Data, Direction, Impact Announcement, Press Release Dr. Ira Mellman Joins PICI as President of Research Announcement, Press Release Dr. Karen E. Knudsen Appointed CEO of PICI